Home > JCT>
Biography

Dr. Gilbert D. A. Padula

MI Lacks Cancer Center, USA

 

Email: padulag@trinity-health.org

 

Qualifications

 

1993 M.D., Michigan State University, USA

1987 B.Sc., University of Michigan, USA


Publications (selected)

  1. Padula GDA, Abramson DA, McCormick BA., Brain necrosis after enucleation, external beam cobalt radiotherapy, and systemic chemotherapy for retinoblastoma: a case report. Arch Ophthalmol 2002;120(1): 98-9
  2. Padula GDA, Zelefsky MJ, Venkatraman ES, Fuks Z, Lee HJ, Natale L, Leibel SA., Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52(2):439-43
  3. Padula GDA, Zelefsky MJ, Leibel SA. Editorial response regarding: Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54(3):981
  4. Vecchio FM, Valentini V, Minsky BD, Padula GDA, Venkatraman ES, Balducci M, Micciche F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C., The relationship of pathologic tumor regression grade
  5. (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62(3):752-760
  6. Moller MG, Gribbin T, Ebrom S, Padula G, Fitzgerald TL., Breast cancer metastatic to renal cell carcinoma. Surgery 2006;139(4):577-9.
  7. Padula GDA, Schmitz MD. A case of adult paratesticular malignant fibrous histiocytoma treated with surgery, systemic chemotherapy, and postoperative adjuvant radiotherapy. J Can Res Ther. 2006;2:201-202.
  8. Schmitz MD, Padula GDA, Chun P, Davis A. Normalization of prostate specific antigen (PSA) treated with intensity modulated radiotherapy (IMRT) for clinically localized prostate cancer. Radiat Oncol. 2010 Sep 16; 5:80
  9. Digesu C, Cilla S, De Gaetano A, Panunzi S, Iapalucci C, Frascino V, Mantini G, Matiucci GC, Luzi S, Deodato F, Macchia G, D’Angelo E, Padula GDA, Valentini V, Cellini N, Piermattei A, Morganti A. Postoperative IMRT in high risk prostate cancer: a dosimetric comparison. Med Dosim. 2011 Autumn;36(3):231-9
  10. Cilla S, Digesu C, Silvano G, Deodato F, Padula GDA, Macchia G, Piermattei A, Morganti A. Intensity modulated radiotherapy (IMRT) of unresected left-sided pleural mesothelioma: a case report. Tumori. 2010 Jul-Aug:96(4):618-22
  11. Cilla S, Macchia G, Digesu C, Deodato F, Romanella M, Ferrandina G, Padula GDA, Picardi V, Scambia G, Piermatei A, and Morganti AG. 3D-conformal versus intensity-modulated postoperative radiotherapy of vaginal vault: a dosimetric comparison. Med Dosim. 2010;35(2):135-142
  12. Macchia G, Cilla S, Ferrandina G, Padula GDA, Deodato F, Di Gesu C, Caravatta L, Picardi V, Legge F, Piermattei A, Valentini V, Cellini N, Scambia G, Morganti AG. Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a phase I study. Int J Radiat Oncol Biol Phys. 2010;76(5):1390-1395
  13. Deodato F, Cilla S, Grimaldi L, Digesu C, Craus M, Macchia G, Massaccesi M, Padula GDA, Valentini V, Cellini N, Piermattei A, Morganti AG. Optimizing the dose distribution in extracranial stereotactic radiotherapy with standard multileaf collimator (MLC): a dosimetric study. Submitted for Publication.
  14. Macchia G, Ferrandina G, Legge F, Deodato F, Ruggieri V, LoRusso D, Padula GDA, Smaniotto D, Luzi S, Valentini V, Cellini N, Scambia G, Morganti AG. Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase I-II study (ESTER-1) Am J Clin Oncol. 2010 Dec;33(6):577-82
  15. Massaccesi M, Caravatta L, Cilla S, Digesu C, Deodato F, Macchia G, Picardi V, Piscopo A, Padula GDA, Ferrandina G, Scambia G, Valentini V, Cellini N, Piermattei A, Morganti AG. Active breathing coordinator (ABC) in adjuvant 3-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. Tumori. 2010 May-Jun;96(3):417-23.
  16. Ippolito E, Mantini G, Morganti AG, Mazzeo E, Padula GDA, Digesu C, Cilla S, Frascino V, Luzi S, Massaccesi M, Macchia G, Deodato F, Piermattei A, Cellini N. Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity. Am J Clin Oncol. 2012 Apr;35(2):158-62
  17. Caravatta L, Picardi V, Tambaro R, Padula GDA, Macchia G, Deodato F, Massaccesi M, Pacelli F, Berardi S, Ridolfini MP, Di Filippo L, Fabrizio G, Ingrosso M, Cellini N, Valentini V, Morganti AG. Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: a dose-escalation study. Am J Clin Oncol. 2012;35:424-431
  18. Caravatta L, Padula GDA, Picardi V, Macchia G, Deodato F, Massaccesi M, Pacelli F, Cecere G, Sallustio G, Di Lullo L, Piscopo A, Mignogna S, Bonomo P, Cellini N, Valentini V, Morganti AG. Concomittant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. Acta Oncol. 2011 Nov;50(8):1151-7
  19. Caravatta L, Padula GDA, Macchia G, Ferrandina G, Bonomo P, Deodato F, Massaccesi M, Mignogna S, Tambaro R, Rossi M, Flocco M, Di Lullo L, Pacelli F, Valentini V, Cellini N, Morganti AG. Short course accelerated radiation therapy in palliative treatment of advanced pelvic malignancies: a phase I study. Int J Radiation Oncol Biol Phys 2012 Aug 1;83(5):e627-31
  20. Caravatta L, Sallustio G, Tortorelli AP, Padula GDA, Deodato F, Macchia G, Massaccesi M, Picardi V, Cilla S, Marinelli A, Cellini N, Valentini V, Morganti AG. Clinical target volume delineation in preoperative and definitive radiotherapy for the treatment of pancreatic cancer. Radiat Oncol 2012 Jun 12;7:86
  21. Massaccesi M, Caravatta L, Padula GDA, Di Rito S, Abraha A, Rossi M, Di Falco C, Macchia G, Deodato F, Tambaro R, Mignogna S, Flocco M, Pacelli F, Valentini V, Cellini N, Morganti AG. Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center. J Clin Pain 2013 Jan 30
  22. Massaccesi M, Digesu C, Macchia G, Deodato F, Ciuffreda M, Cucci E, Caravatta L, Corrado G, Padula GDA, De Vizia R, Cellini N, Valentini V, Sallustio G, Ferrandina G, Pacelli F, Morganti AG. Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? Br J Radiol 2012 Sep;85(1017):e682-5
  23. Morganti AG, Buwenge M, Cilla S, Padula GDA, Marinelli A, Digesu C, Deodato F, Macchia G, Massaccesi M, Picardi V, Bogale S, Caravatta L, Romanella M, Mattiucci GC, Cellini N, Valentini V, Kigula-Mugambe J. Definition of field margins for palliative radiotherapy of pancreatic carcinoma. Radiation Oncology 2012;7:86
  24. Caravatta L, Deodato F, Ferro M, Macchia G, Massaccesi M, Cilla S, Padula GDA, Mignogna S, Tambaro R, Carrozza F, Flocco M, Cantore G, Scapati A, Buwenge M, Sticca G, Valentini V, Cellini N, Morganti AG. A Phase I study of short course accelerated whole brain radiation therapy for multiple brain metastases. Int J Radiation Oncol Biol Phys 2012 Nov 15:84(4):e463-8.